Saroja Pharma Industries India Ltd, founded in 2019 by Mr. Biju Gopinathan Nair and Mr. Manish Dasharath Kamble, is a pharmaceutical and healthcare company that transitioned from a private to a public limited entity in April 2023. The company focuses on trading and manufacturing Active Pharmaceutical Ingredients (API), pharma intermediates, specialty chemicals, and solvents for human and veterinary medicine. This transition has allowed Saroja Pharma to access a broader investor base and expand its market presence.
The company's commitment to high-quality products and customer-centric service has garnered both domestic and international recognition. Saroja Pharma plans to further enhance its capabilities through a public issue of 10,84,800 equity shares, aiming to raise Rs 9.11 Crores. This capital will support the company's growth and its strategic objectives in the global healthcare market. With a focus on innovation and integration, Saroja Pharma is positioned to make a significant impact in the industry.
